High Content Screening Market Outlook, Research With GE Healthcare, Merck Group, Yokogawa, Genedata, BD, Danaher

This High Content Screening market report also investigates and discusses significant industry trends, estimations of market size, and market share. The report also considers the various inhibitors and motivators of the market in both quantitative and qualitative way so that users get correct information.

Global high content screening market is expected to rise from its initial estimated value of USD 623.29 million to an estimated value of USD 1427.10 million by 2026, registering a CAGR of 10.91% in the forecast period of 2019-2026. This rise in market value can be attributed to the increasing healthcare services.

Get Free Sample of This Market Information: https://databridgemarketresearch.com/request-a-sample/?dbmr=global-high-content-screening-market

Market Definition: Global High Content Screening Market

High content screening which is also known as high- content analysis or cellomics, is a method which uses microscopic imaging so that they can observe, measure and analyze multiple parameters within  cells. This can be done using multi- parameter image processing, automated microscopy and visualizing tools so that data can be collected from the cell populations.

 Key Market Competitors: Global High Content Screening Market

Few of the major competitors currently working in the high content screening market are General Electric Company, Danaher, PerkinElmer Inc., Thermo Fisher Scientific Inc., BD, BioTek Instruments, Inc., Bio-Rad Laboratories, Inc., Tecan Trading AG, Yokogawa India Ltd., Merck KGaA, TTP Labtech, Thorlabs, Inc., Molecular Devices, LLC., Olympus Corporation, Essen BioScience, Inc., Merck KGaA, Evotec A.G., Genedata AG, Cell Signaling Technology, Sysmex Corporation.

 Market Drivers:

Increasing investments in R&D

Technological advancement in the imaging solutions is driving the growth of this market.

 Key Developments in the Market:

In February 2019, Ncardia announced the launch of their DiscoveryHIT drug screening platform which will help the researcher to access human diseases early in the drug discovery process. The aim is to provide better medicines to the patients.

In June 2017, GE Healthcare Lifesciences announced the launch of their new IN Carta image analysis software which will combine powerful analytics with an intuitive user interface and will provide fast, quantitative results from images acquired on IN Cell Analyzer system. Without the need for complex pre or post processing operations, this software can extract the information needed for downstream phenotypic analysis.

Get TOC For Full Analysis Of Report: https://databridgemarketresearch.com/toc/?dbmr=global-high-content-screening-market 

Market Segmentation: Global High Content Screening Market

By Product

Instruments

Flow Cytometers

Cell Analyzers

Cell Sorters

Cell Imaging and Analysis Systems

Consumables

Reagents and Assay Kits

Microplates

Other Consumables

Software

Services

Accessories

By Applications

Primary and Secondary Screening

Target Identification and Validation

Toxicity Studies

Compound Profiling

Other Applications

By End- User

Pharmaceutical and Biotechnology Companies

Academic and Government Institutes

Contract Research Organizations

By Geography

North America

 

Canada

Mexico

South America

Brazil

Argentina

Rest of South America

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Turkey

Belgium

Netherlands

Switzerland

Rest of Europe

Asia-Pacific

Japan

China

South Korea

India

Australia

Singapore

Thailand

Malaysia

Indonesia

Philippines

Rest of Asia- Pacific

Middle East & Africa

South Africa

Egypt

Saudi Arabia

United Arab Emirates

Israel

Rest of Middle East & Africa

Want Full Report? Enquire Here: https://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-high-content-screening-market

About Us

Data Bridge Market Research is a versatile market research and consulting firm with over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Our coverage of industries include Medical Devices, Pharmaceuticals, Biotechnology, Semiconductors, Machinery, Information and Communication Technology, Automobiles and Automotive, Chemical and Material, Packaging, Food and Beverages, Cosmetics, Specialty Chemicals, Fast Moving Consumer Goods, Robotics, among many others.

Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. Get Customization and Discount on Report by emailing Corporatesales@databridgemarketresearch.com . We are content with our glorious 99.9 % client satisfying rate.

Contact Us

Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475
Mail: Corporatesales@databridgemarketresearch.com
https://databridgemarketresearch.com